Bacil Pharma Ltd.
Fundamentals
- Market cap
- ₹76 cr
- P/E
- 103.84×
- ROE
- 1.59%
- Debt / equity
- 0.01
- 52-week range
- 26.69 — 61.80
The timeline — 2 notes on Bacil Pharma Ltd.
May 2026
- 22 May 26 · 20:50 IST Brief Brief · Earnings
Bacil Pharma remains non-operational as annual profit masks losses
The company reported zero operating revenue for FY26, relying on other income to post a bottom-line profit.
- 22 May 26 · 20:46 IST Brief Brief · Earnings
Bacil Pharma reports zero revenue for FY26
The nano-cap firm remains non-operational, relying on investment income to fund a loss of ₹61.88 lakhs.